Site-related differences in the localization of the monoclonal antibody OX7 in SL2 and SL1 lymphomas
- PMID: 3731201
- PMCID: PMC11038596
- DOI: 10.1007/BF00200028
Site-related differences in the localization of the monoclonal antibody OX7 in SL2 and SL1 lymphomas
Abstract
The uptake of a monoclonal antibody (OX7) by murine lymphomas (SL1, SL2) growing in two sites in the mouse were compared. SL2 tumors grown in the subrenal site showed greater specific antibody uptake than did the same tumor grown in the subcutaneous site. Major differences in membrane bound antibody, in vitro antibody binding patterns, and gamma scintillation camera imaging were also observed between the two sites. These differences may be due to the greater blood flow measured in tumors growing in the subrenal capsule than those growing at the subcutaneous site. The differences observed in antibody uptake of the same tumor growing in two different sites raises questions concerning the choice of animal model systems that can be used to predict clinical utility.
Similar articles
-
The imaging of small experimental murine tumors grown in the subrenal capsule using monoclonal antibodies.Cancer Lett. 1984 Aug;24(1):65-72. doi: 10.1016/0304-3835(84)90081-8. Cancer Lett. 1984. PMID: 6498801
-
An immunotoxin composed of monoclonal anti-Thy 1.1 antibody and a ribosome-inactivating protein from Saponaria officinalis: potent antitumor effects in vitro and in vivo.J Natl Cancer Inst. 1985 Jul;75(1):151-9. J Natl Cancer Inst. 1985. PMID: 3859688
-
Experimental radiotherapy of murine lymphoma with 131I-labeled anti-Thy 1.1 monoclonal antibody.Cancer Res. 1985 Apr;45(4):1536-44. Cancer Res. 1985. PMID: 3978621
-
Radioimmunoscintigraphy of lymphoma with monoclonal antibodies.Cancer Treat Res. 1988;38:209-22. doi: 10.1007/978-1-4613-1713-5_5. Cancer Treat Res. 1988. PMID: 2908596 Review. No abstract available.
-
Monoclonal antibody patterns in cutaneous lymphoid infiltrates. Their possible relevance to the diagnosis and categorization of cutaneous lymphomas.Dermatol Clin. 1985 Oct;3(4):593-603. Dermatol Clin. 1985. PMID: 2947768 Review.
Cited by
-
The detection of virally induced tumors by 131I- and 125I-labeled syngeneic monoclonal antibodies.Cancer Immunol Immunother. 1988;26(3):243-9. doi: 10.1007/BF00199936. Cancer Immunol Immunother. 1988. PMID: 3164257 Free PMC article.
-
Histamine, leukotriene C4 and interleukin-2 increase antibody uptake into a human carcinoma xenograft model.Br J Cancer. 1991 Nov;64(5):872-4. doi: 10.1038/bjc.1991.416. Br J Cancer. 1991. PMID: 1931608 Free PMC article.
-
Altered biodistribution of indium-111-labeled monoclonal antibody 96.5 to tumors and normal tissues of nude mice bearing human melanoma xenografts in visceral organs.Cancer Immunol Immunother. 1989;30(5):257-61. doi: 10.1007/BF01744891. Cancer Immunol Immunother. 1989. PMID: 2624918 Free PMC article.
-
Monoclonal antibodies for the treatment of metastases. Evaluation of strategies using a syngeneic rat model.Cell Biophys. 1993 Jan-Jun;22(1-3):165-87. doi: 10.1007/BF03033873. Cell Biophys. 1993. PMID: 7889538
References
-
- Ackerman NB, Hechmer PA. Comparison of vascular permeability of tumors and liver host tissues. Bibl Anat. 1977;15:304–306. - PubMed
-
- Ballou B, Levine G, Hakala RJ, Solter D. Tumor location detected with radioactively labelled monoclonal antibodies and external scintigraphy. Science. 1979;206:844–847. - PubMed
-
- Bogden A, Kelton D, Cobb W, Esber H (1978) A rapid screening method for testing chemotherapeutic agents against human xenografts, In: Houchens DP, Ovejera AA, Fischer Gustav (eds) Proceedings of Symposium on the Use of Athymic (Nude) Mice in Cancer Research. New York, pp 231–250
-
- Colcher D, Keenan AM, Larson SM, Schlom J. Prolonged binding of a radiolabeled monoclonal antibody (B72.3) used in the in situ radioimmunodetection of human colon carcinoma xenografts. Cancer Res. 1981;44:5744–5751. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical